Loading...

True-Nuclear™ Transcription Factor Buffer Set True-Nuclear™ Transcription Factor Buffer Set

Pricing & Availability
Regulatory Status
RUO
Other Names
Transcription Factor Fixation/Permeabilization Buffer Set
Ave. Rating
Submit a Review
Product Citations
publications
Transcription_Factor_F_P_Buffer_1_ICFC_012915
Human peripheral blood lymphocytes were surface stained with CD3 APC and then treated with True-Nuclear™ Transcription Factor Buffer Set. Cells were then stained with T-bet (clone 4B10) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).
  • Transcription_Factor_F_P_Buffer_1_ICFC_012915
    Human peripheral blood lymphocytes were surface stained with CD3 APC and then treated with True-Nuclear™ Transcription Factor Buffer Set. Cells were then stained with T-bet (clone 4B10) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).
  • Transcription_Factor_F_P_Buffer_2_ICFC_012915
Cat # Size Price Quantity Check Availability Save
424401 120 tests DKK981
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

BioLegend's True-Nuclear™ Transcription Factor Buffer Set has been specially formulated for intracellular staining with minimum effect on the surface fluorochrome staining.

See the advantages of True-Nuclear™ Transcription Factor Buffer Set in this brief webinar: biolegend.com/true_nuclear_webinar.


 

Caution: The True-Nuclear™ Transcription Factor Buffer Set contains paraformaldehyde, which is toxic and mutagenic. Please handle with caution. Wear gloves, lab coats, and necessary protection to avoid direct contact. 

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Prepare fresh Transcription Factor Fix working solution by diluting the 4X Fix Concentrate (1 part) with the Fix Diluent (3 parts). 1 mL of the 1X Fix working solution is needed for each tube.

Prepare a 1X working solution of the Perm Buffer by diluting the 10X Perm Buffer with distilled water. 6.5 mL of 1X Perm Buffer is needed for each sample of tube.

NOTE: The 10X Perm Buffer may have crystallization or precipitation when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is a heavy precipitation observed after dilution to 1X working solution, it can be filtered to clarify the solution.

Application Notes

Buffer Set Contents:

  • True-Nuclear™ 4X Fix Concentrate (30 mL)
  • True-Nuclear™ Fix Diluent (100 mL)
  • True-Nuclear™ 10X Perm Buffer (100 mL)

 

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells, to detect transcription factors, and to study TIGIT in our Scientific Poster Library.

Product Citations
  1. Wang L, et al. 2019. Front Pharmacol. 1.342361111. PubMed
  2. Douglass SM, et al. 2021. Cancer Res. 81:658. PubMed
  3. Capelle CM, et al. 2022. Immunology. 165:428. PubMed
  4. Ellis GI, et al. 2022. Cell Rep Med. 3:100614. PubMed
  5. Grant NL, et al. 2022. Cell Rep. 39:110826. PubMed
  6. Hu M, et al. 2022. Int J Mol Sci. 23: . PubMed
  7. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  8. Yu H, et al. 2022. Hematol Oncol. 40:894. PubMed
  9. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  10. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  11. Noman MZ, et al. 2022. Front Immunol. 13:980704. PubMed
  12. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  13. Ishii T, et al. 2022. Cell Death Discov. 8:480. PubMed
  14. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  15. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  16. Landshammer A, et al. 2023. Elife. 12: . PubMed
  17. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  18. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  19. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  20. Zander R, et al. 2022. Immunity. 55:475. PubMed
  21. de Lemos L, et al. 2022. Development. 149:. PubMed
  22. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  23. Cook ME, et al. 2022. Sci Immunol. 7:eabo0981. PubMed
  24. Whyte CE, et al. 2022. Curr Protoc. 2:e589. PubMed
  25. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  26. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  27. Schwarz A, et al. 2023. Front Immunol. 14:1038689. PubMed
  28. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  29. Yi X, et al. 2023. Signal Transduct Target Ther. 8:107. PubMed
  30. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  31. McKenzie C, et al. 2023. Mol Ther Nucleic Acids. 32:603. PubMed
  32. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  33. Adu-Berchie K, et al. 2023. Nat Commun. 14:3546. PubMed
  34. Manso BA, et al. 2021. STAR Protoc. 2:100485. PubMed
  35. Wu HJ, et al. 2021. Nat Commun. 12:4897. PubMed
  36. Zeng N, et al. 2022. EMBO Rep. 23:e53302. PubMed
  37. Ogawa T, et al. 2020. J Immunol. 205:907. PubMed
  38. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  39. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  40. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  41. Bujanover N, et al. 2021. Stem Cell Reports. 16:1884. PubMed
  42. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  43. Zhang M, et al. 2020. Nat Commun. 4.707638889. PubMed
  44. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  45. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  46. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  47. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  48. Guo R, et al. 2020. Nat Microbiol. 0.938194444. PubMed
  49. van der Heiden M, et al. 2020. Scand J Immunol. e13005:. PubMed
  50. Baram T, et al. 2021. Cells. 10:. PubMed
  51. Lin H, et al. 2020. Front Microbiol. 1.330555556. PubMed
  52. Fronik P, et al. 2021. J Med Chem. 64:12132. PubMed
  53. Webster MR, et al. 2020. Mol Cell. 77:633. PubMed
  54. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  55. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  56. Prodinger J, et al. 2016. J Leukoc Biol. 99: 583-594. PubMed
  57. Noman MZ, et al. 2020. Sci Adv. 6:eaax7881. PubMed
  58. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  59. Cortez JT, et al. 2020. Nature. 582:416. PubMed
  60. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  61. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  62. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  63. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  64. Ng W, et al. 2021. Pharm Biol. 59:47:00. PubMed
  65. Tian X, et al. 2021. Annals of Translational Medicine. 9(9):781. PubMed
  66. Wei SC, et al. 2020. Cancer Discov. . PubMed
  67. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  68. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  69. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  70. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  71. Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed
  72. Jarjour NN, et al. 2019. Nat Immunol. 1.310416667. PubMed
  73. de Andrade LF, et al. 2019. JCI Insight. 4:e133103. PubMed
  74. Pucella JN, et al. 2019. J Immunol. 202:1383. PubMed
  75. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  76. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  77. Swartz AM, et al. 2022. Curr Protoc. 2:e410. PubMed
  78. Shiao SL, et al. 2021. Cancer Cell. 39:1202. PubMed
  79. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  80. Woodruff M, et al. 2020. medRxiv. . PubMed
  81. Ellis GI, et al. 2022. STAR Protoc. 3:101784. PubMed
  82. Wiarda JE, et al. 2022. Life Sci Alliance. 5:. PubMed
  83. Qiao J, et al. 2019. Cancer Cell. 35:901. PubMed
  84. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  85. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  86. Lü X, et al. 2021. Exp Ther Med. 22:1005. PubMed
  87. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  88. Hu HJ, et al. 2021. Cancer Immunol Immunother. 70:3541. PubMed
  89. Ye Z, et al. 2021. Nat Commun. 12:907. PubMed
  90. Saito E, et al. 2019. Biomaterials. 222:119432. PubMed
  91. Bin L, et al. 2017. APMIS. 10.1111/apm.12748. PubMed
  92. Rasmussen TA, et al. 2022. Cell Rep Med. 3:100766. PubMed
  93. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  94. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  95. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  96. Kleiman E, et al. 2021. Sci Rep. 11:9561. PubMed
  97. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  98. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  99. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  100. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  101. Ye Z, et al. 2021. NPJ Aging Mech Dis. 7:4. PubMed
  102. Xu L, et al. 2020. Nat Cell Biol. 1162:22. PubMed
  103. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  104. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  105. Okuma A, et al. 2017. Nat Commun.. 10.1038/s41467-017-02281-x. PubMed
  106. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  107. Datlinger P, et al. 2017. Nat Methods. 10.1038/nmeth.4177. PubMed
  108. Jarjour NN, et al. 2020. J Immunol. 204:923. PubMed
  109. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  110. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  111. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  112. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  113. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  114. Feng Y, et al. 2019. Stem Cell Res Ther. 0.479166667. PubMed
  115. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  116. Capelle CM, et al. 2021. Immunohorizons. 5:711. PubMed
  117. Lone W, et al. 2021. Clin Cancer Res. 27:6039. PubMed
  118. Chen Y, et al. 2021. Nat Immunol. 22:996. PubMed
  119. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  120. Alhudaithi SS, et al. 2020. Mol Pharm. 17:4691. PubMed
  121. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  122. Andricovich J, et al. 2016. J Clin Invest. 126:905-20. PubMed
  123. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  124. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  125. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  126. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  127. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  128. Zhu P, et al. 2022. Cell Commun Signal. 20:121. PubMed
  129. Zhao J, et al. 2021. Front Oncol. 10:621092. PubMed
  130. Prosser A, et al. 2021. STAR Protoc. 2:100810. PubMed
  131. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  132. Gonzalez MM, et al. 2021. J Clin Invest. 131:. PubMed
  133. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  134. Moritsch S, et al. 2022. Oncoimmunology. 11:2127271. PubMed
  135. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  136. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  137. Vora AA, et al. 2021. STAR Protocols. 2(2):100565. PubMed
  138. Wang L, et al. 2019. Front Pharmacol. 1.342361111. PubMed
  139. Douglass SM, et al. 2021. Cancer Res. 81:658. PubMed
  140. Capelle CM, et al. 2022. Immunology. 165:428. PubMed
  141. Ellis GI, et al. 2022. Cell Rep Med. 3:100614. PubMed
  142. Grant NL, et al. 2022. Cell Rep. 39:110826. PubMed
  143. Hu M, et al. 2022. Int J Mol Sci. 23: . PubMed
  144. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  145. Yu H, et al. 2022. Hematol Oncol. 40:894. PubMed
  146. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  147. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  148. Noman MZ, et al. 2022. Front Immunol. 13:980704. PubMed
  149. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  150. Ishii T, et al. 2022. Cell Death Discov. 8:480. PubMed
  151. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  152. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  153. Landshammer A, et al. 2023. Elife. 12: . PubMed
  154. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  155. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  156. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  157. Zander R, et al. 2022. Immunity. 55:475. PubMed
  158. de Lemos L, et al. 2022. Development. 149:. PubMed
  159. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  160. Cook ME, et al. 2022. Sci Immunol. 7:eabo0981. PubMed
  161. Whyte CE, et al. 2022. Curr Protoc. 2:e589. PubMed
  162. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  163. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  164. Schwarz A, et al. 2023. Front Immunol. 14:1038689. PubMed
  165. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  166. Yi X, et al. 2023. Signal Transduct Target Ther. 8:107. PubMed
  167. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  168. McKenzie C, et al. 2023. Mol Ther Nucleic Acids. 32:603. PubMed
  169. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  170. Adu-Berchie K, et al. 2023. Nat Commun. 14:3546. PubMed
  171. Manso BA, et al. 2021. STAR Protoc. 2:100485. PubMed
  172. Wu HJ, et al. 2021. Nat Commun. 12:4897. PubMed
  173. Zeng N, et al. 2022. EMBO Rep. 23:e53302. PubMed
  174. Ogawa T, et al. 2020. J Immunol. 205:907. PubMed
  175. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  176. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  177. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  178. Bujanover N, et al. 2021. Stem Cell Reports. 16:1884. PubMed
  179. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  180. Zhang M, et al. 2020. Nat Commun. 4.707638889. PubMed
  181. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  182. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  183. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  184. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  185. Guo R, et al. 2020. Nat Microbiol. 0.938194444. PubMed
  186. van der Heiden M, et al. 2020. Scand J Immunol. e13005:. PubMed
  187. Baram T, et al. 2021. Cells. 10:. PubMed
  188. Lin H, et al. 2020. Front Microbiol. 1.330555556. PubMed
  189. Fronik P, et al. 2021. J Med Chem. 64:12132. PubMed
  190. Webster MR, et al. 2020. Mol Cell. 77:633. PubMed
  191. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  192. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  193. Prodinger J, et al. 2016. J Leukoc Biol. 99: 583-594. PubMed
  194. Noman MZ, et al. 2020. Sci Adv. 6:eaax7881. PubMed
  195. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  196. Cortez JT, et al. 2020. Nature. 582:416. PubMed
  197. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  198. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  199. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  200. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  201. Ng W, et al. 2021. Pharm Biol. 59:47:00. PubMed
  202. Tian X, et al. 2021. Annals of Translational Medicine. 9(9):781. PubMed
  203. Wei SC, et al. 2020. Cancer Discov. . PubMed
  204. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  205. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  206. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  207. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  208. Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed
  209. Jarjour NN, et al. 2019. Nat Immunol. 1.310416667. PubMed
  210. de Andrade LF, et al. 2019. JCI Insight. 4:e133103. PubMed
  211. Pucella JN, et al. 2019. J Immunol. 202:1383. PubMed
  212. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  213. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  214. Swartz AM, et al. 2022. Curr Protoc. 2:e410. PubMed
  215. Shiao SL, et al. 2021. Cancer Cell. 39:1202. PubMed
  216. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  217. Woodruff M, et al. 2020. medRxiv. . PubMed
  218. Ellis GI, et al. 2022. STAR Protoc. 3:101784. PubMed
  219. Wiarda JE, et al. 2022. Life Sci Alliance. 5:. PubMed
  220. Qiao J, et al. 2019. Cancer Cell. 35:901. PubMed
  221. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  222. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  223. Lü X, et al. 2021. Exp Ther Med. 22:1005. PubMed
  224. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  225. Hu HJ, et al. 2021. Cancer Immunol Immunother. 70:3541. PubMed
  226. Ye Z, et al. 2021. Nat Commun. 12:907. PubMed
  227. Saito E, et al. 2019. Biomaterials. 222:119432. PubMed
  228. Bin L, et al. 2017. APMIS. 10.1111/apm.12748. PubMed
  229. Rasmussen TA, et al. 2022. Cell Rep Med. 3:100766. PubMed
  230. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  231. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  232. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  233. Kleiman E, et al. 2021. Sci Rep. 11:9561. PubMed
  234. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  235. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  236. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  237. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  238. Ye Z, et al. 2021. NPJ Aging Mech Dis. 7:4. PubMed
  239. Xu L, et al. 2020. Nat Cell Biol. 1162:22. PubMed
  240. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  241. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  242. Okuma A, et al. 2017. Nat Commun.. 10.1038/s41467-017-02281-x. PubMed
  243. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  244. Datlinger P, et al. 2017. Nat Methods. 10.1038/nmeth.4177. PubMed
  245. Jarjour NN, et al. 2020. J Immunol. 204:923. PubMed
  246. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  247. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  248. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  249. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  250. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  251. Feng Y, et al. 2019. Stem Cell Res Ther. 0.479166667. PubMed
  252. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  253. Capelle CM, et al. 2021. Immunohorizons. 5:711. PubMed
  254. Lone W, et al. 2021. Clin Cancer Res. 27:6039. PubMed
  255. Chen Y, et al. 2021. Nat Immunol. 22:996. PubMed
  256. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  257. Alhudaithi SS, et al. 2020. Mol Pharm. 17:4691. PubMed
  258. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  259. Andricovich J, et al. 2016. J Clin Invest. 126:905-20. PubMed
  260. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  261. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  262. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  263. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  264. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  265. Zhu P, et al. 2022. Cell Commun Signal. 20:121. PubMed
  266. Zhao J, et al. 2021. Front Oncol. 10:621092. PubMed
  267. Prosser A, et al. 2021. STAR Protoc. 2:100810. PubMed
  268. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  269. Gonzalez MM, et al. 2021. J Clin Invest. 131:. PubMed
  270. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  271. Moritsch S, et al. 2022. Oncoimmunology. 11:2127271. PubMed
  272. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  273. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  274. Vora AA, et al. 2021. STAR Protocols. 2(2):100565. PubMed

Antigen Details

Cell Type
Tregs
Biology Area
Immunology, Transcription Factors
Molecular Family
Nuclear Markers
Gene ID
NA
Go To Top Version: 5    Revision Date: 05/20/2020

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Transcription Factor Fixation/Permeabilization Buffer Set
Ave. Rating
Submit a Review
Product Citations
publications
Transcription_Factor_F_P_Buffer_1_ICFC_012915
Human peripheral blood lymphocytes were surface stained with CD3 APC and then treated with True-Nuclear™ Transcription Factor Buffer Set. Cells were then stained with T-bet (clone 4B10) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).
  • Transcription_Factor_F_P_Buffer_1_ICFC_012915
    Human peripheral blood lymphocytes were surface stained with CD3 APC and then treated with True-Nuclear™ Transcription Factor Buffer Set. Cells were then stained with T-bet (clone 4B10) Brilliant Violet 421™ (top) or mouse IgG1, κ Brilliant Violet 421™ isotype control (bottom).
  • Transcription_Factor_F_P_Buffer_2_ICFC_012915
Cat # Size Price Quantity Check Availability Save
424401 120 tests DKK981
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

BioLegend's True-Nuclear™ Transcription Factor Buffer Set has been specially formulated for intracellular staining with minimum effect on the surface fluorochrome staining.

See the advantages of True-Nuclear™ Transcription Factor Buffer Set in this brief webinar: biolegend.com/true_nuclear_webinar.


 

Caution: The True-Nuclear™ Transcription Factor Buffer Set contains paraformaldehyde, which is toxic and mutagenic. Please handle with caution. Wear gloves, lab coats, and necessary protection to avoid direct contact. 

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Prepare fresh Transcription Factor Fix working solution by diluting the 4X Fix Concentrate (1 part) with the Fix Diluent (3 parts). 1 mL of the 1X Fix working solution is needed for each tube.

Prepare a 1X working solution of the Perm Buffer by diluting the 10X Perm Buffer with distilled water. 6.5 mL of 1X Perm Buffer is needed for each sample of tube.

NOTE: The 10X Perm Buffer may have crystallization or precipitation when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is a heavy precipitation observed after dilution to 1X working solution, it can be filtered to clarify the solution.

Application Notes

Buffer Set Contents:

  • True-Nuclear™ 4X Fix Concentrate (30 mL)
  • True-Nuclear™ Fix Diluent (100 mL)
  • True-Nuclear™ 10X Perm Buffer (100 mL)

 

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells, to detect transcription factors, and to study TIGIT in our Scientific Poster Library.

Product Citations
  1. Wang L, et al. 2019. Front Pharmacol. 1.342361111. PubMed
  2. Douglass SM, et al. 2021. Cancer Res. 81:658. PubMed
  3. Capelle CM, et al. 2022. Immunology. 165:428. PubMed
  4. Ellis GI, et al. 2022. Cell Rep Med. 3:100614. PubMed
  5. Grant NL, et al. 2022. Cell Rep. 39:110826. PubMed
  6. Hu M, et al. 2022. Int J Mol Sci. 23: . PubMed
  7. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  8. Yu H, et al. 2022. Hematol Oncol. 40:894. PubMed
  9. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  10. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  11. Noman MZ, et al. 2022. Front Immunol. 13:980704. PubMed
  12. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  13. Ishii T, et al. 2022. Cell Death Discov. 8:480. PubMed
  14. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  15. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  16. Landshammer A, et al. 2023. Elife. 12: . PubMed
  17. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  18. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  19. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  20. Zander R, et al. 2022. Immunity. 55:475. PubMed
  21. de Lemos L, et al. 2022. Development. 149:. PubMed
  22. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  23. Cook ME, et al. 2022. Sci Immunol. 7:eabo0981. PubMed
  24. Whyte CE, et al. 2022. Curr Protoc. 2:e589. PubMed
  25. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  26. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  27. Schwarz A, et al. 2023. Front Immunol. 14:1038689. PubMed
  28. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  29. Yi X, et al. 2023. Signal Transduct Target Ther. 8:107. PubMed
  30. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  31. McKenzie C, et al. 2023. Mol Ther Nucleic Acids. 32:603. PubMed
  32. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  33. Adu-Berchie K, et al. 2023. Nat Commun. 14:3546. PubMed
  34. Manso BA, et al. 2021. STAR Protoc. 2:100485. PubMed
  35. Wu HJ, et al. 2021. Nat Commun. 12:4897. PubMed
  36. Zeng N, et al. 2022. EMBO Rep. 23:e53302. PubMed
  37. Ogawa T, et al. 2020. J Immunol. 205:907. PubMed
  38. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  39. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  40. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  41. Bujanover N, et al. 2021. Stem Cell Reports. 16:1884. PubMed
  42. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  43. Zhang M, et al. 2020. Nat Commun. 4.707638889. PubMed
  44. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  45. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  46. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  47. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  48. Guo R, et al. 2020. Nat Microbiol. 0.938194444. PubMed
  49. van der Heiden M, et al. 2020. Scand J Immunol. e13005:. PubMed
  50. Baram T, et al. 2021. Cells. 10:. PubMed
  51. Lin H, et al. 2020. Front Microbiol. 1.330555556. PubMed
  52. Fronik P, et al. 2021. J Med Chem. 64:12132. PubMed
  53. Webster MR, et al. 2020. Mol Cell. 77:633. PubMed
  54. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  55. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  56. Prodinger J, et al. 2016. J Leukoc Biol. 99: 583-594. PubMed
  57. Noman MZ, et al. 2020. Sci Adv. 6:eaax7881. PubMed
  58. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  59. Cortez JT, et al. 2020. Nature. 582:416. PubMed
  60. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  61. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  62. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  63. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  64. Ng W, et al. 2021. Pharm Biol. 59:47:00. PubMed
  65. Tian X, et al. 2021. Annals of Translational Medicine. 9(9):781. PubMed
  66. Wei SC, et al. 2020. Cancer Discov. . PubMed
  67. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  68. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  69. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  70. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  71. Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed
  72. Jarjour NN, et al. 2019. Nat Immunol. 1.310416667. PubMed
  73. de Andrade LF, et al. 2019. JCI Insight. 4:e133103. PubMed
  74. Pucella JN, et al. 2019. J Immunol. 202:1383. PubMed
  75. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  76. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  77. Swartz AM, et al. 2022. Curr Protoc. 2:e410. PubMed
  78. Shiao SL, et al. 2021. Cancer Cell. 39:1202. PubMed
  79. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  80. Woodruff M, et al. 2020. medRxiv. . PubMed
  81. Ellis GI, et al. 2022. STAR Protoc. 3:101784. PubMed
  82. Wiarda JE, et al. 2022. Life Sci Alliance. 5:. PubMed
  83. Qiao J, et al. 2019. Cancer Cell. 35:901. PubMed
  84. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  85. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  86. Lü X, et al. 2021. Exp Ther Med. 22:1005. PubMed
  87. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  88. Hu HJ, et al. 2021. Cancer Immunol Immunother. 70:3541. PubMed
  89. Ye Z, et al. 2021. Nat Commun. 12:907. PubMed
  90. Saito E, et al. 2019. Biomaterials. 222:119432. PubMed
  91. Bin L, et al. 2017. APMIS. 10.1111/apm.12748. PubMed
  92. Rasmussen TA, et al. 2022. Cell Rep Med. 3:100766. PubMed
  93. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  94. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  95. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  96. Kleiman E, et al. 2021. Sci Rep. 11:9561. PubMed
  97. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  98. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  99. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  100. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  101. Ye Z, et al. 2021. NPJ Aging Mech Dis. 7:4. PubMed
  102. Xu L, et al. 2020. Nat Cell Biol. 1162:22. PubMed
  103. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  104. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  105. Okuma A, et al. 2017. Nat Commun.. 10.1038/s41467-017-02281-x. PubMed
  106. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  107. Datlinger P, et al. 2017. Nat Methods. 10.1038/nmeth.4177. PubMed
  108. Jarjour NN, et al. 2020. J Immunol. 204:923. PubMed
  109. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  110. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  111. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  112. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  113. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  114. Feng Y, et al. 2019. Stem Cell Res Ther. 0.479166667. PubMed
  115. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  116. Capelle CM, et al. 2021. Immunohorizons. 5:711. PubMed
  117. Lone W, et al. 2021. Clin Cancer Res. 27:6039. PubMed
  118. Chen Y, et al. 2021. Nat Immunol. 22:996. PubMed
  119. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  120. Alhudaithi SS, et al. 2020. Mol Pharm. 17:4691. PubMed
  121. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  122. Andricovich J, et al. 2016. J Clin Invest. 126:905-20. PubMed
  123. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  124. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  125. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  126. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  127. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  128. Zhu P, et al. 2022. Cell Commun Signal. 20:121. PubMed
  129. Zhao J, et al. 2021. Front Oncol. 10:621092. PubMed
  130. Prosser A, et al. 2021. STAR Protoc. 2:100810. PubMed
  131. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  132. Gonzalez MM, et al. 2021. J Clin Invest. 131:. PubMed
  133. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  134. Moritsch S, et al. 2022. Oncoimmunology. 11:2127271. PubMed
  135. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  136. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  137. Vora AA, et al. 2021. STAR Protocols. 2(2):100565. PubMed
  138. Wang L, et al. 2019. Front Pharmacol. 1.342361111. PubMed
  139. Douglass SM, et al. 2021. Cancer Res. 81:658. PubMed
  140. Capelle CM, et al. 2022. Immunology. 165:428. PubMed
  141. Ellis GI, et al. 2022. Cell Rep Med. 3:100614. PubMed
  142. Grant NL, et al. 2022. Cell Rep. 39:110826. PubMed
  143. Hu M, et al. 2022. Int J Mol Sci. 23: . PubMed
  144. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  145. Yu H, et al. 2022. Hematol Oncol. 40:894. PubMed
  146. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  147. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  148. Noman MZ, et al. 2022. Front Immunol. 13:980704. PubMed
  149. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  150. Ishii T, et al. 2022. Cell Death Discov. 8:480. PubMed
  151. Chen X, et al. 2022. J Extracell Vesicles. 11:e12279. PubMed
  152. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  153. Landshammer A, et al. 2023. Elife. 12: . PubMed
  154. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  155. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  156. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  157. Zander R, et al. 2022. Immunity. 55:475. PubMed
  158. de Lemos L, et al. 2022. Development. 149:. PubMed
  159. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  160. Cook ME, et al. 2022. Sci Immunol. 7:eabo0981. PubMed
  161. Whyte CE, et al. 2022. Curr Protoc. 2:e589. PubMed
  162. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  163. Li Y, et al. 2023. Adv Mater. 35:e2208923. PubMed
  164. Schwarz A, et al. 2023. Front Immunol. 14:1038689. PubMed
  165. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  166. Yi X, et al. 2023. Signal Transduct Target Ther. 8:107. PubMed
  167. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  168. McKenzie C, et al. 2023. Mol Ther Nucleic Acids. 32:603. PubMed
  169. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  170. Adu-Berchie K, et al. 2023. Nat Commun. 14:3546. PubMed
  171. Manso BA, et al. 2021. STAR Protoc. 2:100485. PubMed
  172. Wu HJ, et al. 2021. Nat Commun. 12:4897. PubMed
  173. Zeng N, et al. 2022. EMBO Rep. 23:e53302. PubMed
  174. Ogawa T, et al. 2020. J Immunol. 205:907. PubMed
  175. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  176. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  177. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  178. Bujanover N, et al. 2021. Stem Cell Reports. 16:1884. PubMed
  179. Kim D, et al. 2021. Nanomicro Lett. 13:31. PubMed
  180. Zhang M, et al. 2020. Nat Commun. 4.707638889. PubMed
  181. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  182. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  183. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  184. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  185. Guo R, et al. 2020. Nat Microbiol. 0.938194444. PubMed
  186. van der Heiden M, et al. 2020. Scand J Immunol. e13005:. PubMed
  187. Baram T, et al. 2021. Cells. 10:. PubMed
  188. Lin H, et al. 2020. Front Microbiol. 1.330555556. PubMed
  189. Fronik P, et al. 2021. J Med Chem. 64:12132. PubMed
  190. Webster MR, et al. 2020. Mol Cell. 77:633. PubMed
  191. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  192. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  193. Prodinger J, et al. 2016. J Leukoc Biol. 99: 583-594. PubMed
  194. Noman MZ, et al. 2020. Sci Adv. 6:eaax7881. PubMed
  195. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  196. Cortez JT, et al. 2020. Nature. 582:416. PubMed
  197. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  198. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  199. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  200. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  201. Ng W, et al. 2021. Pharm Biol. 59:47:00. PubMed
  202. Tian X, et al. 2021. Annals of Translational Medicine. 9(9):781. PubMed
  203. Wei SC, et al. 2020. Cancer Discov. . PubMed
  204. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  205. Freitas JT, et al. 2021. Pigment Cell Melanoma Res. 34:1084. PubMed
  206. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  207. He X, et al. 2021. Adv Sci (Weinh). 8:e2103023. PubMed
  208. Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed
  209. Jarjour NN, et al. 2019. Nat Immunol. 1.310416667. PubMed
  210. de Andrade LF, et al. 2019. JCI Insight. 4:e133103. PubMed
  211. Pucella JN, et al. 2019. J Immunol. 202:1383. PubMed
  212. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  213. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  214. Swartz AM, et al. 2022. Curr Protoc. 2:e410. PubMed
  215. Shiao SL, et al. 2021. Cancer Cell. 39:1202. PubMed
  216. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  217. Woodruff M, et al. 2020. medRxiv. . PubMed
  218. Ellis GI, et al. 2022. STAR Protoc. 3:101784. PubMed
  219. Wiarda JE, et al. 2022. Life Sci Alliance. 5:. PubMed
  220. Qiao J, et al. 2019. Cancer Cell. 35:901. PubMed
  221. Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
  222. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  223. Lü X, et al. 2021. Exp Ther Med. 22:1005. PubMed
  224. Li Y, et al. 2021. Cell Death Dis. 12:1001. PubMed
  225. Hu HJ, et al. 2021. Cancer Immunol Immunother. 70:3541. PubMed
  226. Ye Z, et al. 2021. Nat Commun. 12:907. PubMed
  227. Saito E, et al. 2019. Biomaterials. 222:119432. PubMed
  228. Bin L, et al. 2017. APMIS. 10.1111/apm.12748. PubMed
  229. Rasmussen TA, et al. 2022. Cell Rep Med. 3:100766. PubMed
  230. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  231. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  232. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  233. Kleiman E, et al. 2021. Sci Rep. 11:9561. PubMed
  234. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  235. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  236. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  237. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  238. Ye Z, et al. 2021. NPJ Aging Mech Dis. 7:4. PubMed
  239. Xu L, et al. 2020. Nat Cell Biol. 1162:22. PubMed
  240. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  241. Yao C, et al. 2018. Autophagy. 1.854861111. PubMed
  242. Okuma A, et al. 2017. Nat Commun.. 10.1038/s41467-017-02281-x. PubMed
  243. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  244. Datlinger P, et al. 2017. Nat Methods. 10.1038/nmeth.4177. PubMed
  245. Jarjour NN, et al. 2020. J Immunol. 204:923. PubMed
  246. Oherle K, et al. 2020. Immunity. 275:52. PubMed
  247. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  248. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  249. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  250. Chen C, et al. 2020. Front Cell Neurosci. 14:8. PubMed
  251. Feng Y, et al. 2019. Stem Cell Res Ther. 0.479166667. PubMed
  252. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  253. Capelle CM, et al. 2021. Immunohorizons. 5:711. PubMed
  254. Lone W, et al. 2021. Clin Cancer Res. 27:6039. PubMed
  255. Chen Y, et al. 2021. Nat Immunol. 22:996. PubMed
  256. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  257. Alhudaithi SS, et al. 2020. Mol Pharm. 17:4691. PubMed
  258. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  259. Andricovich J, et al. 2016. J Clin Invest. 126:905-20. PubMed
  260. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  261. Zhong C, et al. 2021. J Virol. 95:e0092521. PubMed
  262. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
  263. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  264. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  265. Zhu P, et al. 2022. Cell Commun Signal. 20:121. PubMed
  266. Zhao J, et al. 2021. Front Oncol. 10:621092. PubMed
  267. Prosser A, et al. 2021. STAR Protoc. 2:100810. PubMed
  268. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  269. Gonzalez MM, et al. 2021. J Clin Invest. 131:. PubMed
  270. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  271. Moritsch S, et al. 2022. Oncoimmunology. 11:2127271. PubMed
  272. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  273. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  274. Vora AA, et al. 2021. STAR Protocols. 2(2):100565. PubMed

Antigen Details

Cell Type
Tregs
Biology Area
Immunology, Transcription Factors
Molecular Family
Nuclear Markers
Gene ID
NA
Go To Top Version: 5    Revision Date: 05/20/2020

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account